News

The drug is indicated for the treatment of cleansing of the colon in preparation for colonoscopy in adults. Annual sales for the past 12 months ending July 2016

In addition to the storage and transportation of drugs used in clinical trials as a service offered by all of Marken’s depots, Marken’s newest Moscow Depot will now

The unique multitenant cloud capabilities of Veeva Vault enable Daiichi Sankyo to easily streamline management of its critical content, providing external partners, such as CROs, the same level

PCD is a rare chronic inflammatory bowel disease that is caused by the malfunction of the immune system leading to inflammation, or swelling, across the lining of the

Medivation is focused on the development and commercialization of medically innovative therapies to treat severe diseases that have limited treatment options. The company’s portfolio includes Xtandi (enzalutamide) capsules

The new company, Afimmune, will continue the clinical development of DS102, a novel, anti-fibrotic compound. The company will study DS102 in NASH in addition to certain pulmonary disorders.

The approval of the sNDA is tentative because the FDA has determined that the drug meets all of the required quality, safety, and efficacy standards for approval, but

The Board consists of William Mitchell, M.D., Ph.D., Ronald Brus, M.D., W. Neal Burnette, Ph.D., and Christopher Nicodemus, M.D., F.A.C.P. Dr. Mitchell, M.D., Ph.D., Chairman of the Board

The JV, which was initially announced in December 2015, will focus on the discovery, development and commercialization of new therapeutics to treat blood disorders, blindness, and congenital heart